CI
UTMD icon

Cigna Investments’s Utah Medical Products UTMD Stock Holding History

Cigna Investments’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,745
Closed -$305K – 897
2017
Q4 		$305K Hold
3,745
– – 0.02% 686
2017
Q3 		$275K Hold
3,745
– – 0.02% 703
2017
Q2 		$272K Hold
3,745
– – 0.02% 663
2017
Q1 		$234K Hold
3,745
– – 0.02% 664
2016
Q4 		$272K Buy
+3,745
New +$243K 0.03% 588

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Cigna Investments's UTMD Position: Q1 2018 in Review

Cigna Investments sold out of Utah Medical Products (UTMD) in Q1 2018, closing a stake of 3,745 shares — an estimated $305K sold.

Cigna Investments first reported a position in UTMD in Q4 2016 and held it in 5 quarters. The position peaked at $305K in Q4 2017. 81 funds tracked by Wall St. Rank hold UTMD as of Q1 2018.

  • Cigna Investments reported no remaining Utah Medical Products position as of Q1 2018 after selling out during the quarter.
  • Cigna Investments sold 3,745 Utah Medical Products shares in Q1 2018, an estimated $305K.
  • Cigna Investments first reported a position in Utah Medical Products in Q4 2016 and held it in 5 quarters.
  • Cigna Investments's Utah Medical Products position peaked at $305K in Q4 2017.
  • 81 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2018.

Based on Cigna Investments's 13F filing for Q1 2018, filed 9 May 2018.